BACKGROUND: The effective non-invasive identification of coronary artery disease (CAD) and its proper referral for invasive treatment are still unresolved issues. We evaluated our quantification of myocardium at risk (MAR) from our second generation 3D MPI/CTA fusion framework for the detection and localization of obstructive coronary disease. METHODS: Studies from 48 patients who had rest/stress MPI, CTA, and ICA were analyzed from 3 different institutions. From the CTA, a 3D biventricular surface of the myocardium with superimposed coronaries was extracted and fused to the perfusion distribution. Significant lesions were identified from CTA readings and positioned on the fused display. Three estimates of MAR were computed on the 3D LV surface on the basis of the MPI alone (MARp), the CTA alone (MARa), and the fused information (MARf). The extents of areas at risk were used to generate ROC curves using ICA anatomical findings as reference standard. RESULTS: Areas under the ROC curve (AUC) for CAD detection using MARf was 0.88 (CI = 0.75-0.95) and for MARp and MARa were, respectively 0.82 (CI = 0.69-0.92) and 0.75 (CI = 0.60-0.86) using the ≥70% stenosis criterion. AUCs for CAD localization (all vessels) using MARf showed significantly higher performance than either MARa or MARp or both. CONCLUSIONS: Using ICA as the reference standard, MAR as the quantitative parameter, and AUC to measure diagnostic performance, MPI-CTA fusion imaging provided incremental diagnostic information compared to MPI or CTA alone for the diagnosis and localization of CAD.
BACKGROUND: The effective non-invasive identification of coronary artery disease (CAD) and its proper referral for invasive treatment are still unresolved issues. We evaluated our quantification of myocardium at risk (MAR) from our second generation 3D MPI/CTA fusion framework for the detection and localization of obstructive coronary disease. METHODS: Studies from 48 patients who had rest/stress MPI, CTA, and ICA were analyzed from 3 different institutions. From the CTA, a 3D biventricular surface of the myocardium with superimposed coronaries was extracted and fused to the perfusion distribution. Significant lesions were identified from CTA readings and positioned on the fused display. Three estimates of MAR were computed on the 3D LV surface on the basis of the MPI alone (MARp), the CTA alone (MARa), and the fused information (MARf). The extents of areas at risk were used to generate ROC curves using ICA anatomical findings as reference standard. RESULTS: Areas under the ROC curve (AUC) for CAD detection using MARf was 0.88 (CI = 0.75-0.95) and for MARp and MARa were, respectively 0.82 (CI = 0.69-0.92) and 0.75 (CI = 0.60-0.86) using the ≥70% stenosis criterion. AUCs for CAD localization (all vessels) using MARf showed significantly higher performance than either MARa or MARp or both. CONCLUSIONS: Using ICA as the reference standard, MAR as the quantitative parameter, and AUC to measure diagnostic performance, MPI-CTA fusion imaging provided incremental diagnostic information compared to MPI or CTA alone for the diagnosis and localization of CAD.
Authors: J W Peifer; N F Ezquerra; C D Cooke; R Mullick; L Klein; M E Hyche; E V Garcia Journal: IEEE Trans Biomed Eng Date: 1990-08 Impact factor: 4.538
Authors: Pim A L Tonino; William F Fearon; Bernard De Bruyne; Keith G Oldroyd; Massoud A Leesar; Peter N Ver Lee; Philip A Maccarthy; Marcel Van't Veer; Nico H J Pijls Journal: J Am Coll Cardiol Date: 2010-06-22 Impact factor: 24.094
Authors: Tracy L Faber; Cesar A Santana; Ernest V Garcia; Jaume Candell-Riera; Russell D Folks; John W Peifer; Andrew Hopper; Santiago Aguade; Joan Angel; J Larry Klein Journal: J Nucl Med Date: 2004-05 Impact factor: 10.057
Authors: Piotr J Slomka; Victor Y Cheng; Damini Dey; Jonghye Woo; Amit Ramesh; Serge Van Kriekinge; Yasuzuki Suzuki; Yaron Elad; Ronald Karlsberg; Daniel S Berman; Guido Germano Journal: J Nucl Med Date: 2009-09-16 Impact factor: 10.057
Authors: Cesar A Santana; Ernest V Garcia; Tracy L Faber; Gopi K R Sirineni; Fabio P Esteves; Rupan Sanyal; Raghuveer Halkar; Mario Ornelas; Liudmila Verdes; Stamatios Lerakis; Julie J Ramos; Santiago Aguadé-Bruix; Hugo Cuéllar; Jaume Candell-Riera; Paolo Raggi Journal: J Nucl Cardiol Date: 2009-01-22 Impact factor: 5.952
Authors: Andrew J Einstein; Daniel S Berman; James K Min; Robert C Hendel; Thomas C Gerber; J Jeffrey Carr; Manuel D Cerqueira; S James Cullom; Robert DeKemp; Neal W Dickert; Sharmila Dorbala; Reza Fazel; Ernest V Garcia; Raymond J Gibbons; Sandra S Halliburton; Jörg Hausleiter; Gary V Heller; Scott Jerome; John R Lesser; Gilbert L Raff; Peter Tilkemeier; Kim A Williams; Leslee J Shaw Journal: J Am Coll Cardiol Date: 2014-02-13 Impact factor: 24.094
Authors: Marina Piccinelli; Tracy L Faber; Chesnal D Arepalli; Vikram Appia; Jakob Vinten-Johansen; Susan L Schmarkey; Russell D Folks; Ernest V Garcia; Anthony Yezzi Journal: J Nucl Cardiol Date: 2013-11-02 Impact factor: 5.952
Authors: Mouaz H Al-Mallah; Timothy M Bateman; Kelley R Branch; Andrew Crean; Eric L Gingold; Randall C Thompson; Sarah E McKenney; Edward J Miller; Venkatesh L Murthy; Koen Nieman; Todd C Villines; Michael V Yester; Andrew J Einstein; John J Mahmarian Journal: J Nucl Cardiol Date: 2022-09-02 Impact factor: 3.872
Authors: Piotr J Slomka; Jonathan B Moody; Robert J H Miller; Jennifer M Renaud; Edward P Ficaro; Ernest V Garcia Journal: J Nucl Cardiol Date: 2020-10-16 Impact factor: 5.952